DXCM | Dexcom inc - Stock Value & PE Ratio Analysis

3

24

15

Excellent Growth

AI analysis rates DXCM with the highest value score of 5.
It is mainly due to stable revenue growth, along with adequate operating cash flow.
Over the past 3 months, DXCM has maintained a consecutive value rating of 5.0, slightly higher than the rating of 4.0 over the past 3 years, indicating continued upward trend in enterprise value.
Compared to all stocks in the Health Care sector, DXCM has a higher value rating.

DXCM Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/05/03 (Weekly Update)

DXCM Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

DXCM Earnings Table

Unit : USD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	0.32	-36%	-2.2%	1.04B	0.1%	1.8%	13.6%
2024Q2	0.45	-10%	2.3%	994.2M	2%	0.4%	14.3%
2024Q1	0.43	26.5%	10.3%	1B	15.3%	-3.2%	15.9%
2023Q4	0.32	88.2%	18.5%	921M	24.2%	1.2%	24.8%
2023Q3	0.5	47.1%	16.3%	1.03B	26.9%	2%	12.4%

Update to 2025/5/8 (Quarterly Update)

DXCM Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

DXCM Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of DXCM from 2007/01 till Now

1901.47%
Cumulative Return: 17.79%
Annual Return: 39.39%
Volatility: 0.45
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to May, 2025. (Total Trades: 3)